什么时候使用特兰克萨姆酸治疗严重出血?
Zoe K McQuilten1, Erica M Wood1, Robert L Medcalf2
1School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia; Department of Haematology, Monash Health, Melbourne, Victoria, Australia.
Journal of thrombosis and haemostasis : JTH
|October 12, 2023
概括
特兰胺酸 (TXA) 是一种抗纤维素解药物,用于治疗活跃出血. 它的有效性和安全性因临床背景,剂量和时间而异,早期服用对于创伤和产后出血至关重要.
科学领域:
- 药理学 药理学是指药理学的学科.
- 关键护理医学 关键护理医学
- 血液学 血液学 血液学
背景情况:
- 特兰胺酸 (TXA) 是一种抗纤维素分解剂,最初用于产后出血 (PPH).
- 在过去的15年里,证据越来越多地证明了TXA在各种活跃出血场景中的使用.
- TXA的疗效和安全性取决于环境,受服用时间和剂量的影响.
研究的目的:
- 在各种临床环境中审查TXA对活跃出血的现有证据.
- 强调需要针对血静干预的特定环境的疗效和安全数据.
- 强调个体患者对出血和血栓风险的评估的重要性.
主要方法:
- 临床试验和有关特兰胺酸的现有文献的系统综述.
- 在不同出血情境 (如创伤,PPH,胃肠道出血,脑内出血) 中分析TXA疗效和安全数据.
- 影响TXA有效性的因素的评估,包括给药时间和剂量.
主要成果:
- 早期TXA的使用对于创伤和PPH的疗效至关重要.
- 在主要出血患者中没有整体增加的血栓形成风险,但在胃肠道出血中增加了静脉血栓形成风险.
- 较高的TXA剂量与发作风险增加有关.
结论:
- 在不同临床环境中,TXA的有效性和安全性概况有很大差异.
- 需要进一步的研究来阐明TXA的机制,最佳剂量和在特定条件下使用,如脑内出血.
- 个性化患者评估和特定背景的证据对于优化TXA治疗和患者结果至关重要.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
726
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
726
01:29Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
01:30Venous Thrombosis IV: Nursing Management
14
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
14
01:28Esophageal Varices-II: Clinical Features and Management
74
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
74
01:20Extrinsic and Intrinsic Pathways of Hemostasis
8.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.1K